Return
Company Page
ViewsML Technologies
Founders
ViewsML is building the world's first virtual biomarker library, leveraging artificial intelligence to transform spatial biology for translational research and precision medicine. The company's platform virtualizes immunohistochemistry (IHC) and biomarkers, bypassing traditional wet lab processes to deliver per-cell spatial biomarker insights from standard pathology images. ViewsML works with leading pharmaceutical companies, hospitals, and diagnostic labs to accelerate drug development, clinical trials, and patient care by enabling scientists and clinicians to analyze biomarker staining in minutes rather than days or weeks.
Company Founded in 2022
Healthtech & Biotech